US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 3.095
  • +0.075+2.48%
Trading Nov 19 11:21 ET
93.39MMarket Cap-1082P/E (TTM)

Relmada Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 14, 2024

Based on 3 analysts giving stock ratings to Relmada Therapeutics in the past 3 months

Strong Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: Nov 14, 2024

The average Relmada Therapeutics stock price target is 15.33 with a max estimate of 23.00 and a min estimate of 10.00

Review Relmada Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 14, 2024

Strong Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

Updated: Nov 14, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data